SCHEMBL23735671

SCHEMBL23735671

NC(O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 3/20 0.56
SLC1A3 P43003 2/20 0.56
SLC1A2 P43004 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 2/20 0.56
MEN1 O00255 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
KMT2A Q03164 1/20 0.56
IDO1 P14902 1/20 0.50
AGXT P21549 1/20 0.48
TSHR P16473 2/20 0.48
CA1 P00915 4/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
CA7 P43166 1/20 0.46
EPHX1 P07099 1/20 0.44
TACR1 P25103 2/20 0.44
ALDH1A1 P00352 2/20 0.42
PTGS1 P23219 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1877816 0.81 SLC1A3 (0.55) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL6774653 0.81 TSHR (0.52) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL13174889 0.79 SLC1A3 (0.50) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL26128246 0.79 SLC1A3 (0.50) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL2597854 0.79 SLC1A3 (0.50) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL20403336 0.79 SLC1A3 (0.50) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
Bromide SCHEMBL29032034 0.79 CA1 (0.50) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL3655454 0.79 SLC1A3 (0.53) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL8775978 0.78 SLC1A3 (0.49) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19
SCHEMBL8775968 0.78 SLC1A1 (0.53) SLC1A1SLC1A3SLC1A2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3862362-A2 CONJUGATES OF MODIFIED ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR MODULATING PKK EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2021-08-11 EP disclosed